Endocrine disrupters and human health: A non-exhaustive review;Perturbateurs de la fonction endocrinienne et santé: Un point non exhaustif sur les connaissances

Environnement, Risques et Sante

Volumn 4, Issue 3, 2005, Pages 195-204

  Desmots, Sophie ^a   Brulez, Catherine ^a   Lemazurier, Emmanuel ^a  

^a INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

Author keywords

DNA methylation; Endocrine system; Health; Risk assessment; Xenobiotics

Indexed keywords

ENDOCRINE DISRUPTOR; XENOBIOTIC AGENT;

CONSENSUS; DATA ANALYSIS; DNA METHYLATION; ECOTOXICITY; ENDOCRINE DISEASE; EXPERT SYSTEM; GONADAL DYSGENESIS; HUMAN; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; UNCERTAINTY;

EID: 20644435149     PISSN: 16350421     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Vos JG, Dybing E, Greim HA, et al. Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European situation. Crit Rev Toxicol 2000; 30: 71-133.
2. Blus LJ, Gish CD, Belisle AA, Prouty RM. Further analysis of the logarithmic relationship of DDE residues to eggshell thinning. Nature 1972; 240: 164-6.
3. Hutchinson JD, Simmonds MP. Organochlorine contamination in pinnipeds. Rev Environ Contam Toxicol 1994; 136: 123-67.
4. Guillette Jr. LJ, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 1994; 102: 680-8.
5. Sumpter JP, Jobling S. Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ Health Perspect 1995; 103 (S7): 173-8.
6. Hawkins SJ, Gibbs PE, Pope ND, et al. Recovery of polluted ecosystems: the case for long-term studies. Mar Environ Res 2002; 54: 215-22.
7. Gill WB, Schumacher GF, Bibbo M, Straus FH, Schoenberg HW. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 1979; 122: 36-9.
8. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993; 101: 378-84.
9. Colborn T, Dumanoski D, Myers JP. Our Stolen Future: are we threatening our fertility, intelligence and survival. New York: Dutton; Penguin Books, 1996; 306 p.
10. Multi-organic risk assessment of endocrine disrupters - Workshop -Mallorca, Spain - 31st March-1st April 2004. Toxicology 2004; 205 (NS): 123-30.
11. Safe S. Endocrine disruptors and human health: is there a problem. Toxicology 2004; 205: 3-10.
12. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for the decreasing quality of semen during the past 50 years. BMJ 1992; 305: 609-12.
13. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the mâle reproductive tract. Lancet 1993; 341: 1392-5.
14. Skakkebaek NE, Rajpert-De ME, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16: 972-8.
15. Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analyses in 1283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 1996; 65: 1009-14.
16. Ekbom A, Wicklund-Glynn A, Adami HO. DDT and testicular cancer. Nature 1996; 347: 553-4.
17. Jorgensen N, Carlsen E, Ingrid N, et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002; 17: 219-28.
18. Bergstrom R, Adami HO, Mohner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996; 88: 727-33.
19. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect 1999; 107: 297-302.
20. Joffe M. Time trends in biological fertility in Britain. Lancet 2000; 355: 1961-5.
21. Akre O, Cnattingius S, Bergstrom R, Kvist U, Trichopoulos D, Ekbom A. Human fertility does not decline: evidence from Sweden. Fertil Steril 1999; 71: 1066-9.
22. Swerdlow AJ, De Stavola BL, Swanwick MA, Maconochie NE. Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 1997; 350: 1723-8.
23. Storgaard L, Bonde JP, Ernst E, Andersen CY, Kyvik KO, Olsen J. Effect of prenatal exposure to oestrogen on quality of semen: comparison of twins and singleton brothers. BMJ 2002; 325: 252-3.
24. Pennisi E. Behind the scenes of gene expression. Science 2001; 293: 1064-7.
25. Holliday R. Mechanisms for the control of gene activity during development. Biol Rev Camb Philos Soc 1990; 65: 431-71.
26. Monk M. Epigenetic programming of differential gene expression in development and evolution. Dev Genet 1995; 17: 188-97.
27. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004; 17: 1733-6.
28. Gruenert DC, Cozens AL. Inheritance of phenotype in mammalian cells: genetic vs. epigenetic mechanisms. Am J Physiol 1991; 260: L386-94.
29. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993; 366: 362-5.
30. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Cenet 2000; 1: 11-9.
31. Petronis A. Human morbid genetics revisited: relevance of epigenetics. Trends Genet 2001; 17: 142-6.
32. Counts JL, Goodman JI. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 1995; 83: 13-5.
33. Robertson KD, Jones PA. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 1998; 18: 6457-73.
34. Goodman JI, Watson RE. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu Rev Pharmacol Toxicol 2002; 42: 501-25.
35. Laird PW. Oncogenic mechanisms mediated by DNA methylation. Mol Med Today 1997; 3: 223-9.
36. Jirtle RL. Genomic imprinting and cancer. Exp Cell Res 1999; 248: 18-24.
37. McLachlan JA, Burow M, Chiang TC, Li SF. Gene imprinting in developmental toxicology: a possible interface between physiology and pathology. Toxicol Lett 2001; 120: 161-4.
38. Li S, Washburn KA, Moore R, et al. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 1997; 57: 4356-9.
39. Ferguson AT, Evron E, Umbricht CB, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000; 97: 6049-54.
40. Tomooka Y, DiAugustine RP, McLachlan JA. Proliferation of mouse uterine epithelial cells in vitro. Endocrinology 1986; 118: 1011-8.
41. Nelson KG, Takahashi T, Bossert NL, Walmer DK, McLachlan JA. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci USA 1991; 88: 21-5.
42. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 1992; 89: 4658-62.
43. Curtis SW, Washburn T, Sewall C, et al. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 1996; 93: 12626-30.